ReP USP - Resultado da busca

Artigo de periodico
Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses (2017)
Kronenberger, Thales; Asse Junior, Leonardo Rander; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honorio, Kathia Maria; Maltarollo, Vinícius Gonçalves
Fonte: Future Medicinal Chemistry. Unidades: EACH, ICB, FCF
Assuntos: STAPHYLOCOCCUS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 13 nov. 2024.
APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179
NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc-2016-0179
Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc-2016-0179
Artigo de periodico
Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations (2016)
Maltarollo, Vinícius Gonçalves; Araujo, Sheila Cruz; Trossini, Gustavo Henrique Goulart ; Honorio, Káthia Maria
Fonte: Future Medicinal Chemistry. Unidades: EACH, FCF
Assuntos: DIABETES MELLITUS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations. Future Medicinal Chemistry, v. 8, n. 16, p. 1913-1926, 2016Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0061. Acesso em: 13 nov. 2024.
APA
Maltarollo, V. G., Araujo, S. C., Trossini, G. H. G., & Honorio, K. M. (2016). Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations. Future Medicinal Chemistry, 8( 16), 1913-1926. doi:10.4155/fmc-2016-0061
NLM
Maltarollo VG, Araujo SC, Trossini GHG, Honorio KM. Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations [Internet]. Future Medicinal Chemistry. 2016 ; 8( 16): 1913-1926.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc-2016-0061
Vancouver
Maltarollo VG, Araujo SC, Trossini GHG, Honorio KM. Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations [Internet]. Future Medicinal Chemistry. 2016 ; 8( 16): 1913-1926.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc-2016-0061
Artigo de periodico
Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors (2015)
Maltarollo, Vinícius Gonçalves; Honório, Káthia Maria; Emery, Flavio da Silva; Ganesa, Arasu; Trossini, Gustavo Henrique Goulart
Fonte: Future Medicinal Chemistry. Unidades: EACH, FCFRP, FCF
Assuntos: INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, HOLOGRAMAS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors. Future Medicinal Chemistry, v. 7, n. 11, p. 1381-1394, 2015Tradução . . Disponível em: https://doi.org/10.4155/fmc.15.68. Acesso em: 13 nov. 2024.
APA
Maltarollo, V. G., Honório, K. M., Emery, F. da S., Ganesa, A., & Trossini, G. H. G. (2015). Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors. Future Medicinal Chemistry, 7( 11), 1381-1394. doi:10.4155/fmc.15.68
NLM
Maltarollo VG, Honório KM, Emery F da S, Ganesa A, Trossini GHG. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors [Internet]. Future Medicinal Chemistry. 2015 ; 7( 11): 1381-1394.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc.15.68
Vancouver
Maltarollo VG, Honório KM, Emery F da S, Ganesa A, Trossini GHG. Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors [Internet]. Future Medicinal Chemistry. 2015 ; 7( 11): 1381-1394.[citado 2024 nov. 13 ] Available from: https://doi.org/10.4155/fmc.15.68

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em